Performance of idarucizumab as antidote of dabigatran in daily clinical practice

SJ van der Wall, N van Rein, B van den Bemt, Marieke Kruip, K Meijer, LCJ te Boome, TA Simmers, AM Alings, R Tieleman, PE Westerweel, F Klok, M Huisman

Research output: Contribution to journalArticleAcademicpeer-review

30 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)414-420
Number of pages7
JournalEuropace
Volume21
Issue number3
DOIs
Publication statusPublished - 2019

Cite this